Why Should You Stay Invested in CME Group (CME) Stock Now?

03:20pm, Friday, 23'rd Dec 2022 Zacks Investment Research
CME Group's (CME) global presence, compelling product portfolio, and focus on over-the-counter clearing services and effective capital deployment poise it well for growth.
CME Group's (CME) global presence, compelling product portfolio, and focus on over-the-counter clearing services and effective capital deployment poise it well for growth.

Are Options Traders Betting on a Big Move in CME Group (CME) Stock?

03:04pm, Wednesday, 21'st Dec 2022 Zacks Investment Research
Investors need to pay close attention to CME Group (CME) stock based on the movements in the options market lately.
These dividend stocks give their investors an extra special payment each year.

Building A $100,000 Market-Crushing Dividend Portfolio

12:30pm, Monday, 19'th Dec 2022 Seeking Alpha
In this article, I start by explaining the theoretical background behind the success of dividend (growth) investing. Read more here.
These dividend stocks give their investors an extra special payment each year.

Why Tomorrow Could Be a Huge Day for the Stock Market

12:10pm, Monday, 12'th Dec 2022 The Motley Fool
New inflation data is due out in the morning, and the Federal Reserve's final meeting of the year kicks off.
Analog Devices, The Southern Company, Canadian Pacific Railway, CME Group and UBS are included in this Analyst Blog.

Top Stock Reports for Analog Devices, Southern Company & Canadian Pacific Railway

09:42pm, Wednesday, 07'th Dec 2022 Zacks Investment Research
Today's Research Daily features new research reports on 16 major stocks, including Analog Devices, Inc. (ADI), Southern Company (SO) and Canadian Pacific Railway Limited (CP).
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Symbotic Inc (NASDAQ: SYM) is a "money-losing SPAC. We’re not recommending any money losers." "Everybody’s in this darn business," Cramer
Weekly summary of dividend activity for Dividend Champions, Contenders, Challengers. Read more to see companies with upcoming ex-dividend dates.
Estimated income for 2022 is up to a record $15,545, while the portfolio continues to crush the S&P 500. Buying was light as the market is up big from the October lows. I am skeptical of the market an
U.S. oil prices on Monday briefly erase their year-to-date gain as uncertainty surrounds Chinese energy demand and an OPEC+ output decision looms.
RPC or rate-per-contract continues to slide. CME has managed the business with excellent expense and margin control.

CME (CME) Up 1.9% Since Last Earnings Report: Can It Continue?

04:31pm, Friday, 25'th Nov 2022 Zacks Investment Research
CME (CME) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE